Hematopoietic repopulating ability of CD34+ progenitor cells ex vivo expanded with different cytokine combinations

被引:7
|
作者
Du, Zheng [1 ]
Jin, Huili [1 ]
Cai, Haibo [1 ]
Yang, Shi [1 ]
Tan, Wen-song [1 ]
机构
[1] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
CD34(+) cells; cytokine combination; hematopoietic repopulating ability; multi-lineage reconstitution; NOD/SCID mice; UMBILICAL-CORD BLOOD; NOD/SCID MICE; FLK2/FLT3; LIGAND; BONE-MARROW; STEM-CELLS; EXPANSION; ENGRAFTMENT; RECONSTITUTION; TRANSPLANTATION; THROMBOPOIETIN;
D O I
10.3109/21691401.2014.897630
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Ex-vivo expansion technologies were developed for application of hematopoietic stem cells (HSCs) derived from cord blood (CB). The cytokine combination was essential to expand HSCs ex vivo and maintain the function of expanded HSCs. However the optimal cytokine combination was not determined. In this study, two combinations of cytokines were applied in ex-vivo expansion of HSCs to investigate the effect on the hematopoietic repopulating ability of expanded HSCs. CB CD34(+) cells were expanded with SCF + TPO + FL (STF) or SCF + TPO + FL + IL-3 + IL-6 (STF36) for 7 days and got 30.3 +/- 6.4 and 39.8 +/- 7.3 folds of total cells, respectively. The cells cultured by both STF and STF36 could engraft and repopulate in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice effectively; however, the STF group achieved higher level of engraftment. These result demonstrated that the cytokine combination of STF36 favored the expansion of cells, while the cytokine combination of STF facilitated the engraftment and multi-lineage repopulating in vivo. These findings may have important implications for the cell therapy.
引用
收藏
页码:398 / 402
页数:5
相关论文
共 50 条
  • [41] Substance P and calcitonin gene-related neuropeptides as novel growth factors for ex vivo expansion of cord blood CD34+ hematopoietic stem cells
    Shahrokhi, Somayeh
    Ebtekar, Massoumeh
    Alimoghaddam, Kamran
    Pourfathollah, Ali Akbar
    Kheirandish, Maryam
    Ardjmand, Alireza
    Shamshiri, Ahmad Reza
    Ghavamzadeh, Ardeshir
    GROWTH FACTORS, 2010, 28 (01) : 66 - 73
  • [42] Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
    Papa, Luena
    Djedaini, Mansour
    Hoffman, Ronald
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (146):
  • [43] Unrestricted somatic stem cells: interaction with CD34+ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential
    Jeltsch, Kathrin Sonja
    Radke, Teja Falk
    Laufs, Stephanie
    Giordano, Frank Anton
    Allgayer, Heike
    Wenz, Frederik
    Zeller, Walter Jens
    Koegler, Gesine
    Fruehauf, Stefan
    Maier, Patrick
    CYTOTHERAPY, 2011, 13 (03) : 357 - 365
  • [44] Quantification of CD34+ hematopoietic stem cells from the umbilical cord of dogs
    Massae Nakage, Ana Paula
    Santana, Aureo Evangelista
    Buffo de Capua, Maria Luisa
    Godoy, Aline Vieira
    CIENCIA RURAL, 2009, 39 (02): : 434 - 441
  • [45] Noninvasive Bioluminescent Imaging Demonstrates Long-Term Multilineage Engraftment of Ex Vivo-Expanded CD34-Selected Umbilical Cord Blood Cells
    Steiner, David
    Gelovani, Juri
    Savoldo, Barbara
    Robinson, Simon N.
    Decker, William K.
    Brouard, Nathalie
    Najjar, Amer
    Xing, Dongxia
    Yang, Hong
    Li, Sufang
    Marini, Frank
    Zweidler-McKay, Patrick A.
    Bollard, Catherine M.
    Shpall, Elizabeth J.
    Dotti, Gianpietro
    Simmons, Paul J.
    STEM CELLS, 2009, 27 (08) : 1932 - 1940
  • [46] Clinical Scale Ex Vivo Manufacture of Neutrophils From Hematopoietic Progenitor Cells
    Timmins, Nicholas E.
    Palfreyman, Emma
    Marturana, Flavia
    Dietmair, Stefanie
    Luikenga, Sanna
    Lopez, Genghis
    Fung, Yoke Lin
    Minchinton, Robyn
    Nielsen, Lars K.
    BIOTECHNOLOGY AND BIOENGINEERING, 2009, 104 (04) : 832 - 840
  • [47] Ex vivo-expanded bone marrow CD34+ for acute myocardial infarction treatment: in vitro and in vivo studies
    Gunetti, Monica
    Noghero, Alessio
    Molla, Fabiola
    Staszewsky, Lidia Irene
    de Angelis, Noeleen
    Soldo, Annarita
    Russo, Ilaria
    Errichiello, Edoardo
    Frasson, Chiara
    Rustichelli, Deborah
    Ferrero, Ivana
    Gualandris, Anna
    Berger, Massimo
    Geuna, Massimo
    Scacciatella, Paolo
    Basso, Giuseppe
    Marra, Sebastiano
    Bussolino, Federico
    Latini, Roberto
    Fagioli, Franca
    CYTOTHERAPY, 2011, 13 (09) : 1140 - 1152
  • [48] Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis
    Nakamura, Toru
    Koga, Hironori
    Iwamoto, Hideki
    Tsutsumi, Victor
    Imamura, Yasuko
    Naitou, Masako
    Masuda, Atsutaka
    Ikezono, Yu
    Abe, Mitsuhiko
    Wada, Fumitaka
    Sakaue, Takahiko
    Ueno, Takato
    Ii, Masaaki
    Alev, Cantas
    Kawamoto, Atsuhiko
    Asahara, Takayuki
    Torimura, Takuji
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16025
  • [49] No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34+ Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice
    van der Garde, Mark
    Brand, Anneke
    Slot, Manon C.
    de Graaf-Dijkstra, Alice
    Zwaginga, Jaap Jan
    van Hensbergen, Yvette
    STEM CELLS AND DEVELOPMENT, 2015, 24 (12) : 1448 - 1456
  • [50] EXPANSION OF CD34+ HUMAN HEMATOPOIETIC CELLS FROM UMBILICAL CORD BLOOD USING ROLLER BOTTLES
    Andrade-Zaldivar, H.
    Kalixto-Sanchez, M. A.
    Barba de-la Rosa, A. P.
    De Leon-Rodriguez, A.
    REVISTA MEXICANA DE INGENIERIA QUIMICA, 2014, 13 (02): : 379 - 385